MedDataX Logo

HMW-Adiponectin is Raised in Newborns

NCT ID: NCT00438542

Last Updated: 2007-02-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Study Classification

OBSERVATIONAL

Study Start Date

2003-07-31

Study Completion Date

2006-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cross sectional, hospital-based study dealing with adiponectin levels in newborns to mothers with pre-eclampsia. Venus cord blood samples were collected immediately after birth; 30 cases and 62 controls were enrolled into the study. The study was approved by the local ethics committee and all participants gave written consent.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Blood Glucose in Pregnant Non-diabetic Women During Treatment With Betamethasone for Fetal Lung Maturation

NCT06794307

Preterm Birth Hyperglycemia Neonatal Hypoglycemia +1 more
RECRUITING

Longitudinal Measures of Leptin in Pregnant Women Who Developed Preeclampsia

NCT01649167

High-Risk Pregnancy
COMPLETED

Hemodynamic Measurements in Women With Serious Preeclampsia

NCT00199810

Preeclampsia
COMPLETED

A Study of Cerebral-circulatory Response to Intravenous Antihypertensive Treatment in Women With Serious Preeclampsia

NCT00403572

Preeclampsia
COMPLETED

Endothelial Progenitor Cells in Umbilical Cord Blood in Preeclampsia and IUGR

NCT00634855

Preeclampsia IUGR
TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pre-Eclampsia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pre-eclampsia
Maximum Eligible Age

30 Minutes

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Oslo

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lars Morkrid, MD, PhD

Role: STUDY_DIRECTOR

Institute of Clinical Chemistry, Medical Faculty, University of Oslo, Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HMWadpkcb

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fetal Growth and Placental Function in Pregnancies Complicated by Diabetes
NCT04801121 UNKNOWN
Metabolic and Endocrine Status in Women With Prior Preterm Birth
NCT01355536 COMPLETED
Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn
NCT01648855 COMPLETED
Optic Nerve Sheath Measurement and Angiogenic Factors in Patients With Pre-eclampsia.
NCT06122220 RECRUITING NA
Role of Vaspin in Pathophysiology of Pre-eclampsia
NCT06437535 NOT_YET_RECRUITING
Hemodynamic Changes During Normal Pregnancy
NCT00682201 COMPLETED
Serum Markers in Preeclamptic Women
NCT01361737 COMPLETED
Maternal and Fetal Metabolic Changes
NCT06288126 COMPLETED
Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes
NCT03244722 COMPLETED NA
Water Immersion and Changes in the Fetoplacental Circulation
NCT01799343 COMPLETED NA
Early Onset Preeclampsia and Nectin-4
NCT05098691 COMPLETED
Ultrasonographic Evaluation of Fetal Adrenal Gland in Cases of Threatened Preterm Labor
NCT03251794 COMPLETED
Cardiovascular Risk After Preeclampsia
NCT05277233 RECRUITING
Renin and Aldosterone Levels in the Preterm Neonate At Risk for Hypertension
NCT01549444 COMPLETED
Prediction and Prevention of Preeclampsia by First Trimester Ultrasound
NCT01195441 COMPLETED
The Early and Late Contribution of Fasting and Postprandial Triglycerides on Newborn Subcutaneous and Intrahepatic Fat in Pregnancy
NCT04394806 RECRUITING
Biological Changes Associated With High Risk of Preeclampsia in Nulliparous Women
NCT06200571 ENROLLING_BY_INVITATION
Platelet Count Trends in Pre-eclamptic Parturients
NCT00787241 COMPLETED
Glycated Albumin in Pregnancy
NCT03372824 COMPLETED
Preventing Hypotension in Parturients With an Elevated Body Mass Index (BMI)
NCT01481740 COMPLETED PHASE4
Adipokines, Inflammation, Insulin Resistance and Endothelial Dysfunction in Preeclampsia
NCT04455204 COMPLETED
Prognosis of Extremely Premature Birth
NCT01150396 UNKNOWN
Gestational Diabetes Mellitus: "Placental-maternal Crosstalk and Future Health"
NCT05872009 NOT_YET_RECRUITING
PREdelivery Placental Biomarkers- Pregnancy and Delivery Outcome
NCT03100084 UNKNOWN
Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus
NCT01821053 COMPLETED